share_log
Breakings ·  Dec 5, 2024 21:00
Theriva™ Biologics Announces U.S. FDA Guidance on Design of Phase 3 Study of Vcn-01 for the Treatment of Metastatic Pancreatic Cancer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment